![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 14/75 |
(11) | Number of the document | 2825555 |
(13) | Kind of document | T |
(96) | European patent application number | 13709190.6 |
Date of filing the European patent application | 2013-03-12 | |
(97) | Date of publication of the European application | 2015-01-21 |
(45) | Date of publication and mention of the grant of the patent | 2017-07-12 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/054983 |
Date | 2013-03-12 |
(87) | Number | WO 2013/135684 |
Date | 2013-09-19 |
(30) | Number | Date | Country code |
12159276 | 2012-03-13 | EP | |
201261610030 P | 2012-03-13 | US |
(72) |
SCHULZ, Petra, AT
GEHRINGER, Werner, AT
PAPE, Rainer, AT
LEITINGER, Caroline, AT
SCHÖN, Friedrich, AT
RÖMISCH, Jürgen, AT
|
(73) |
Octapharma AG,
Seidenstrasse 2, 8853 Lachen,
CH
|
(54) | MPROVED PROCESS FOR PRODUCTION OF FIBRINOGEN AND FIBRINOGEN PRODUCED THEREBY |
MPROVED PROCESS FOR PRODUCTION OF FIBRINOGEN AND FIBRINOGEN PRODUCED THEREBY |